Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study

Volume: 116, Issue: 37, Pages: 18590 - 18596
Published: Aug 26, 2019
Abstract
Significance Prostate cancer is the most common nonskin cancer in the United States, where approximately 1 in 9 men will be diagnosed in their lifetime. The prostate is near several vital structures, such as the urethra and neurovascular bundle, and whole gland treatments for prostate cancer can disrupt normal urinary, bowel, and sexual functioning. Here we report the initial results of a clinical trial for nanoparticle-based photothermal cancer...
Paper Details
Title
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
Published Date
Aug 26, 2019
Volume
116
Issue
37
Pages
18590 - 18596
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.